Op deze pagina vindt u publicaties van het RECOVAC consortium en de verschillende webinars die in samenwerking met de NVN zijn georganiseerd voor zorgprofessionals. Via de rode link in de titel komt u terecht bij artikel. 

Kho et al. – 2022 oktober – Lancet Infectious Diseases Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial. 

Imhof et al. – 2022 oktober – Transplant DirectSARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Frölke et al. 2022 oktober – Transplant Direct  Predictors of Nonseroconversion to SARS-CoV-2 Vaccinatination in Kidney Transplant Recipients. 

Sanders et al. – 2022 juli – Clinical Infectious Diseases Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Sanders et al. – 2022 april – Transplantation  The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

Bouwmans et al. – 2022 februari – BMC Nephrology Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.

Webinars

Webinar 15 september 2022: ‘Update over COVID-19: preventie, vaccinatie en behandeling bij nierpatiënten’.